Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Counseling patients about allergic rhinitis

K A Swanson1

  • 1College of Pharmacy, University of Oklahoma, Oklahoma City, USA.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|May 1, 1996
PubMed
Summary

Intranasal corticosteroids effectively manage allergic rhinitis with no systemic effects. Pharmacists play a key role in patient education for proper use and allergen avoidance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary care in Cuba: a public health approach.

Health care for women international·1995
Same author

Comprehensive care and the sanatoria: Cuba's response to HIV/AIDS.

The Journal of the Association of Nurses in AIDS Care : JANAC·1995
Same author

DUEs for the '90s: multicentered, outcome-oriented.

Hospital formulary·1994
Same author

Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers.

Antimicrobial agents and chemotherapy·1993
Same author

Mercaptopurine-induced fever in a patient with Crohn's disease.

The Annals of pharmacotherapy·1992
Same author

Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers.

Antimicrobial agents and chemotherapy·1991

Area of Science:

  • Allergy and Immunology
  • Pharmacology

Background:

  • Allergic rhinitis impacts 10% to 30% of the American population.
  • Intranasal corticosteroids represent a primary treatment modality for allergic rhinitis.

Purpose of the Study:

  • To highlight the safety and efficacy of intranasal corticosteroids in allergic rhinitis management.
  • To emphasize the role of pharmacists in patient education regarding intranasal corticosteroid use and allergen avoidance.

Main Methods:

  • Review of current literature on allergic rhinitis treatment.
  • Analysis of the pharmacological profile of intranasal corticosteroids.
  • Assessment of pharmacist-led patient education strategies.

Main Results:

  • Intranasal corticosteroids demonstrate high efficacy in alleviating allergic rhinitis symptoms.
  • Treatment with intranasal corticosteroids is associated with a favorable safety profile, lacking significant systemic effects.
  • Patient education on proper administration technique and allergen avoidance is crucial for optimal outcomes.

Conclusions:

  • Intranasal corticosteroids are a safe and effective first-line therapy for allergic rhinitis.
  • Pharmacist counseling is vital for maximizing therapeutic benefits and ensuring patient adherence.
  • Comprehensive management includes pharmacotherapy and environmental allergen control.

Related Experiment Videos